Chemours director granted 7,182 stock units
Chemours director Alister Cowan reported a grant of 7,182 stock units of Chemours common stock.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Chemours director Alister Cowan reported a grant of 7,182 stock units of Chemours common stock. The units were acquired at a stated price of $0.00 per share as a compensation award. Following this grant, Cowan directly holds 43,881.0397 shares or stock units in total.
The granted stock units, including deferred stock units and dividend equivalent units, will convert one-for-one into Chemours common stock when Cowan separates from service on the Board.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 7,182 | $0.00 | $0.00 |
Footnotes (2)
- F1. Represents stock units that will convert one-for-one to Chemours common stock upon separation from service on the Board.
- F2. Includes deferred stock units and dividend equivalent units.
Key Figures
Key Terms
stock units financial
deferred stock units financial
dividend equivalent units financial
separation from service financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Chemours (CC) director Alister Cowan report in this Form 4 filing?
Are Alister Cowan’s 7,182 Chemours stock units an open-market purchase?
When will Alister Cowan’s Chemours stock units convert into common stock?
What do deferred stock units and dividend equivalent units mean for Chemours director awards?
AI-generated analysis. How Rhea-AI works. Not financial advice.